Response to: Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism [5]

Thrombosis and Haemostasis

Volumn 95, Issue 5, 2006, Pages 908-

  Kyrle, Paul A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME VARIANT; FACTOR VII ACTIVATING PROTEASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

CASE CONTROL STUDY; DISEASE ASSOCIATION; ENZYME POLYMORPHISM; HETEROZYGOTE; HUMAN; ITALY; LETTER; PRIORITY JOURNAL; RECURRENCE RISK; RISK FACTOR; SCREENING; STATISTICAL ANALYSIS; THROMBOSIS PREVENTION; VENOUS THROMBOEMBOLISM;

EID: 33646454585     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-02-0124     Document Type: Letter

References (2)

1. Franchi F, Martinelli I, Biguzzi E, et al. Marburg I polymorphism of factor VII-activating protease and risk of venous thromboembolism. Blood 2006; 107: 1731.
2. Gulesserian T, Hron G, Endler G, et al. Marburg I polymorphism of factor VII-activating protease and risk of recurrent venous thromboembolism. Thromb Haemost 2006; 95: 65-7.